UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 653

Sortiert nach

DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand

Journal of photochemistry and photobiology. B, Biology, 2017-05, Vol.170, p.271-285

2017

Volltextzugriff (PDF)

A robust in vitro Anticancer, Antioxidant and Antimicrobial Agents Based on New Metal‐Azomethine Chelates Incorporating Ag(I), Pd (II) and VO (II) Cations: Probing the Aspects of DNA Interaction

Applied organometallic chemistry, 2020-02, Vol.34 (2), p.n/a

2020

Volltextzugriff (PDF)

Some new Ag(I), VO(II) and Pd(II) chelates incorporating tridentate imine ligand: Design, synthesis, structure elucidation, density functional theory calculations for DNA interaction, antimicrobial and anticancer activities and molecular docking studies

Applied organometallic chemistry, 2019-04, Vol.33 (4), p.n/a

2019

Volltextzugriff (PDF)

Three novel Ni(II), VO(II) and Cr(III) mononuclear complexes encompassing potentially tridentate imine ligand: Synthesis, structural characterization, DNA interaction, antimicrobial evaluation and anticancer activity

Applied organometallic chemistry, 2017-11, Vol.31 (11), p.n/a

2017

Volltextzugriff (PDF)

Novel azomethine Pd (II)‐ and VO (II)‐based metallo‐pharmaceuticals as anticancer, antimicrobial, and antioxidant agents: Design, structural inspection, DFT investigation, and DNA interaction

Journal of physical organic chemistry, 2019-12, Vol.32 (12), p.n/a

2019

Volltextzugriff (PDF)

Design and nonlinear optical properties (NLO) using DFT approach of new Cr(III), VO(II), and Ni(II) chelates incorporating tri-dentate imine ligand for DNA interaction, antimicrobial, anticancer activities and molecular docking studies

Arabian journal of chemistry, 2020-01, Vol.13 (1), p.649-670

2020

Volltextzugriff (PDF)

Modulatory effect of dietary probiotic and prebiotic supplementation on growth, immuno-biochemical alterations, DNA damage, and pathological changes in E. coli-infected broiler chicks

Frontiers in veterinary science, 2022-10, Vol.9, p.964738-964738

2022

Volltextzugriff (PDF)

Law, Culture, and Fear: A Qualitative Study of Health Professionals' Perceptions of Narcotic Use Related to Cancer Pain

Journal of pain & palliative care pharmacotherapy, 2020-04, Vol.34 (2), p.55-62

2020

Volltextzugriff (PDF)

The Middle East Cancer Consortium promotes palliative care

The Lancet (British edition), 2015-04, Vol.385 (9978), p.1620-1621

2015

Volltextzugriff (PDF)

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v8-v30

2015

Volltextzugriff (PDF)

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26 (suppl 5), p.v56-v68

2015

Volltextzugriff (PDF)

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v69-v77

2015

Volltextzugriff (PDF)

Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v40-v55

2015

Volltextzugriff (PDF)

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v126-v132

2015

Volltextzugriff (PDF)

Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies

Parasitology research (1987), 2010-06, Vol.107 (1), p.1-8

2010

Volltextzugriff (PDF)

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v31-v39

2015

Volltextzugriff (PDF)

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v78-v84

2015

Volltextzugriff (PDF)

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v133-v138

2015

Volltextzugriff (PDF)

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up

Annals of oncology, 2015-09, Vol.26, p.v139-v151

2015

Volltextzugriff (PDF)

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v108-v115

2015

Volltextzugriff (PDF)

Central venous access in oncology: ESMO Clinical Practice Guidelines

Annals of oncology, 2015-09, Vol.26, p.v152-v168

2015

Volltextzugriff (PDF)

Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v85-v99

2015

Volltextzugriff (PDF)

Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v100-v107

2015

Volltextzugriff (PDF)

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2015-09, Vol.26, p.v169-v173

2015

Volltextzugriff (PDF)

Unmet needs in cancer patients: Creating recommendations to overcome geographical disparities in economic growth

Clinical nutrition ESPEN, 2023-06, Vol.55, p.267-276

2023

Volltextzugriff (PDF)

1 – 25 von 653

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(476)
Mit Volltextzugriff
(609)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand

A robust in vitro Anticancer, Antioxidant and Antimicrobial Agents Based on New Metal‐Azomethine Chelates Incorporating Ag(I), Pd (II) and VO (II) Cations: Probing the Aspects of DNA Interaction

Some new Ag(I), VO(II) and Pd(II) chelates incorporating tridentate imine ligand: Design, synthesis, structure elucidation, density functional theory calculations for DNA interaction, antimicrobial and anticancer activities and molecular docking studies

Three novel Ni(II), VO(II) and Cr(III) mononuclear complexes encompassing potentially tridentate imine ligand: Synthesis, structural characterization, DNA interaction, antimicrobial evaluation and anticancer activity

Novel azomethine Pd (II)‐ and VO (II)‐based metallo‐pharmaceuticals as anticancer, antimicrobial, and antioxidant agents: Design, structural inspection, DFT investigation, and DNA interaction

Design and nonlinear optical properties (NLO) using DFT approach of new Cr(III), VO(II), and Ni(II) chelates incorporating tri-dentate imine ligand for DNA interaction, antimicrobial, anticancer activities and molecular docking studies

Modulatory effect of dietary probiotic and prebiotic supplementation on growth, immuno-biochemical alterations, DNA damage, and pathological changes in E. coli-infected broiler chicks

Law, Culture, and Fear: A Qualitative Study of Health Professionals' Perceptions of Narcotic Use Related to Cancer Pain

The Middle East Cancer Consortium promotes palliative care

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Central venous access in oncology: ESMO Clinical Practice Guidelines

Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines

Unmet needs in cancer patients: Creating recommendations to overcome geographical disparities in economic growth

Suchergebnisse filtern